Cancer of unknown primary origin: a decade of experience in a community-based hospital

Am J Surg. 2007 Dec;194(6):833-7; discussion 837-8. doi: 10.1016/j.amjsurg.2007.08.039.

Abstract

Background: Cancer of unknown primary (CUP) origin is a very aggressive disease with a poor prognosis. Most of the literature reports of CUP are generated from tertiary cancer centers.

Methods: A retrospective chart review of all patients with a diagnosis of CUP was performed between January 1995 and January 2005. Age, gender, diagnostic evaluation, histologic diagnosis, location of metastases, treatment, and survival were recorded.

Results: Ninety-one patients met the inclusion criteria. The pathologic diagnoses included adenocarcinoma (42.8%), undifferentiated carcinoma (34.5%), squamous cell carcinoma (9.8%), neuroendocrine cancer (6.5%), sarcoma (3.2%), and nonspecific malignant neoplasm (3.2%). The overall mean survival was 9.2 months (95% confidence interval, 6.1-12.4 mo), and for squamous cell carcinoma was 26.9 months (standard error, 5.7; P = .007).

Conclusions: CUP encompasses a variety of different pathologic entities with an overall dismal 5-year survival. Nonetheless, squamous cell and neuroendocrine CUP are associated with a significantly better early prognosis than the other malignancies.

MeSH terms

  • Adenocarcinoma / secondary
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms / secondary
  • Carcinoma / secondary
  • Carcinoma, Neuroendocrine / mortality
  • Carcinoma, Neuroendocrine / secondary
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / secondary
  • Carcinoma, Squamous Cell / therapy
  • Female
  • Head and Neck Neoplasms / secondary
  • Hospitals, Community
  • Hospitals, Teaching
  • Humans
  • Liver Neoplasms / secondary
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Neoplasms, Unknown Primary / epidemiology*
  • Neoplasms, Unknown Primary / mortality
  • Prognosis
  • Retrospective Studies